Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors
Yeun‐Yoon Kim, Jeeyun Lee, Woo Kyoung Jeong, et al.
Gastric Cancer (2020) Vol. 24, Iss. 2, pp. 457-466
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis
Yukinori Takenaka, Ryohei Oya, Norihiko Takemoto, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 5, pp. 1122-1135
Open Access | Times Cited: 88
Prevalence of sarcopenia in patients with solid tumors: A meta‐analysis based on 81,814 patients
Alexey Surov, Andreas Wienke
Journal of Parenteral and Enteral Nutrition (2022) Vol. 46, Iss. 8, pp. 1761-1768
Open Access | Times Cited: 55
Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study
Ji Hyun Lee, Sujin Hyung, Jeeyun Lee, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e005226-e005226
Open Access | Times Cited: 48
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma
Bang‐Bin Chen, Po‐Chin Liang, Tiffany Ting‐Fang Shih, et al.
European Radiology (2022) Vol. 33, Iss. 1, pp. 512-522
Closed Access | Times Cited: 44
Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade
He Meng, Zifan Chen, Li Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e007054-e007054
Open Access | Times Cited: 26
Association of Obesity and Skeletal Muscle with Postoperative Survival in Non–Small Cell Lung Cancer
Ji Hyun Lee, Danbee Kang, Jung Hee Lee, et al.
Radiology (2025) Vol. 314, Iss. 1
Closed Access | Times Cited: 1
Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Shuluan Li, Tianyu Wang, Gangling Tong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 41
Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma
Ji Hyun Lee, Young Cheol Yoon, Hyun Su Kim, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 2, pp. 1076-1086
Open Access | Times Cited: 29
Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis
Paul Trinkner, Sophie Günther, Ina Monsef, et al.
European Journal of Cancer (2023) Vol. 184, pp. 151-171
Closed Access | Times Cited: 19
Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor
Guiming Deng, Dayong Zhu, Zhongze Du, et al.
Cancer Medicine (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 5
Association of Body Composition Parameters with the Short- and Long-Term Efficacy of Neoadjuvant Immunotherapy Combined with Chemotherapy in Advanced Gastric Cancer
Bingyan Cao, Peifang Zhang, Zhanying Shi
Nutrition and Cancer (2025), pp. 1-10
Closed Access
Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review
Laurens S. ter Maat, Isabella A.J. van Duin, Sjoerd G. Elias, et al.
European Journal of Cancer (2022) Vol. 175, pp. 60-76
Open Access | Times Cited: 19
Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis
Alexey Surov, Alexandra Strobel, Jan Borggrefe, et al.
European Radiology (2023) Vol. 33, Iss. 9, pp. 6426-6437
Closed Access | Times Cited: 12
CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
Jiazheng Li, Zifan Chen, Chen Yang, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 11
Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor
Guiming Deng, Haibin Song, Zhongze Du, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 863-880
Open Access | Times Cited: 4
CT‐determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer
Yue Feng, Xiaohong Cheng, Mei Xu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
Toshiaki Tsurui, Kazuyuki Hamada, Emiko Mura, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
A. B. Rays, М. Yu. Fedyanin, D. V. Popov, et al.
(2025)
Open Access
Cachexia Index as a Prognostic Indicator in Patients with Gastric Cancer: A Retrospective Study
Can Gong, Qianyi Wan, Rui Zhao, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4400-4400
Open Access | Times Cited: 17
Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study
Qianyi Wan, Qian Yuan, Rui Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population
Xiaoding Shen, Xing Wang, Zhenjiang Zheng, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10438-10448
Open Access | Times Cited: 9
Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody
Nalee Kim, Jeong Il Yu, Do Hoon Lim, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer
Hongjuan Ji, Bona Liu, Peng Jin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Fully-automated CT derived body composition analysis reveals sarcopenia in functioning adrenocortical carcinomas
Prasanna Santhanam, Roshan Dinparastisaleh, Karteek Popuri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance
Zhenchao Liu, Tianxiang Lei, Yunliang Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top